Generic medicines have benefited millions of Americans and saved $1.5 trillion dollars in the past 10 years. And while much progress has been made, there are still too many off-patent medications that have few or no generic options.
With our Generics Access Plan we can help increase patient access to medicines by facilitating generics competition through new and revised standards, training and education, and collaborations with the FDA, industry representatives and others.
A recently published study by Johns Hopkins University found that drugs with a USP standard have approximately 50% more generic manufacturers in the U.S. than those without a standard. This increased competition was associated with reducing prescription drug costs.